Navigate Fool.com
Will QGEN beat
the market?


Community Rating: 4 Stars: Favorite

24.99 0.11 (0.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.81
Previous Close $24.88
Daily Range $24.65 - $25.02
52-Week Range $19.46 - $25.32
Market Cap $5.8B
P/E Ratio 85.79
Dividend (Yield) $0.00 (0.0%)
Volume 1,086,699
Average Daily Volume 884,549
Current FY EPS $1.08

How do you think QGEN
will perform against the market?

Top QGEN Bull/Bear Pitches


DTCook (< 20)
Submitted March 17, 2014

Leader in personalized-medicine. Working with over 25 pharmaceutical companies developing companion diagnostics.

0 Replies Reply Report this Post

popomike (< 20)
Submitted September 8, 2011

I have demoed their products on a regular basis in the my lab and most of the time I don't like them.

0 Replies Reply Report this Post

News & Commentary

Why Are Companion Diagnostics So Important?

Patients, doctors, and investors have been excited about new frontiers in oncology, but can these drugs be useful without companion diagnostics?

Is Now the Right Time for This Small-Cap Dividend Stock?

Dividends are a great way to boost your portfolio's performance over the long run. Here is the lowdown on a little-known health-care stock that offers a healthy 4% dividend and is trading close to its 52-week low.

QGEN Crosses Above Key Moving Average Level

First Week of June 21st Options Trading For Qiagen (QGEN)

Qiagen Breaks Below 200-Day Moving Average - Notable for QGEN

2014: The Year of Personalized Medicine

After a 2013 of massive improvements to cancer therapy, will 2014 be the year doctors can quickly determine which patients will benefit from which therapies?

Clovis Oncology: The Best-Performing Biotechs of 2013

Here's why Clovis Oncology Inc. (CLVS) has posted a gain of over 200% this year.

5 Stocks With Triple-Digit P/Es That This Value Investor Would Consider Buying

Even if you're a staunch value investor, check out these five stocks for their incredible growth potential.

Stock Upgrades: Ain't No Mountain High Enough for Vail Resorts

Wall street ratings agencies set the tone for today's stock market.

A Growth Story in Molecular Diagnostics

Cepheid is benefiting from the new trends in MDx.

See More QGEN News...




Diversified Services

Qiagen (QGEN) Description

Qiagen is a top provider of genomic testing technology and a leader in molecular diagnostics and related instruments. Website: http://www.qiagen.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks